- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Andalon, imagemedical collaborate on ASP PACS
imagemedical.com and Andalon Health Systems have agreed to work together on providing ASP-based PACS to customers who want to avoid the initial capital equipment investment associated with a full-scale implementation. Andalon will host
imagemedical.com and Andalon Health Systems have agreed to work together on providing ASP-based PACS to customers who want to avoid the initial capital equipment investment associated with a full-scale implementation. Andalon will host imagemedical's PracticeBuilder PACS products by providing systems, infrastructure, bandwidth, and project management. Users will be able to access diagnostic-quality images by connecting to Andalon's servers over the Internet or via a virtual private network. PracticeBuilder applications include image distribution, storage, retrieval, and viewing.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 3.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
